Compare e l f Beauty Inc (ELF) vs Nuwellis Inc (NUWE) Price & Performance

ELF Beauty trades at $109.12, up 3.89% today, and is near its R3 resistance level of $109. The stock shows strong technical momentum with bullish moving averages, though RSI levels above 70 indicate potential overbought conditions. Fundamentally, the company reported revenue of $1.31 billion in 2025 with a net income of $112.09 million, and recent earnings beats in Q4 2025, Q1 2026, and Q2 2026 highlight operational strength. Expansion into Europe via Sephora for the rhode brand and marketing initiatives like the 'Mirror Mix' album signal aggressive growth strategies.

The outlook for ELF is positive given earnings momentum and international expansion, but the high P/E ratio of 108.12 poses valuation risks. Analyst consensus is a 'Buy' with a price target of $95.91, below the current price, suggesting limited near-term upside. Key risks include competitive pressures in the beauty sector and sensitivity to consumer spending trends. Institutional buying activity, such as State Street Corp's increased stake, supports confidence in long-term growth.

NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.

The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.